Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, as represented by the Department of Health and Human Services”

677 pharma patents match "The United States of America, as represented by the Department of Health and Human Services" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 677
Index total 30,257
Page 2 / 29

Quick answer

This filtered view shows 677 pharmaceutical patents matching "The United States of America, as represented by the Department of Health and Human Services" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

677 results for “The United States of America, as represented by the Department of Health and Human Services” · 30,257 patents in full index Clear search

  1. US 8106027

    Development of a preventive vaccine for filovirus infection in primates

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted

  2. US 8101739

    Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted

  3. US 8088379

    Modified T cell receptors and related materials and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 3, 2012 · Expires Dec 29, 2031

    granted

  4. US 8084199

    Method of diagnosing poor survival prognosis colon cancer using microRNA-21

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  5. US 8075903

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  6. US 8076100

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted

  7. US 8071084

    Vaccine for protection against Shigella sonnei disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  8. US 8071113

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted

  9. US 8067530

    Scytovirin domain 1 related polypeptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  10. US 8053443

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  11. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  12. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  13. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  14. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  15. US 8017130

    Method of accelerated vaccination against Ebola viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted

  16. US 8008266

    Methods of treating cancer using immunostimulatory oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted

  17. US 7998736

    Adoptive immunotherapy with enhanced T lymphocyte survival

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 16, 2011 · Expires Aug 11, 2031

    granted

  18. US 7993919

    Method of inducing memory B cell development and terminal differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  19. US 7993857

    Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  20. US 7993921

    Cell cycle regulation and differentiation

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  21. US 7988971

    Human monoclonal antibodies against Hendra and Nipah viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 2, 2011 · Expires Jul 28, 2031

    granted

  22. US 7981610

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  23. US 7977468

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  24. US 7972606

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.